• Nenhum resultado encontrado

A skeletal muscle ryanodine receptor interaction domain in triadin.

N/A
N/A
Protected

Academic year: 2017

Share "A skeletal muscle ryanodine receptor interaction domain in triadin."

Copied!
7
0
0

Texto

Loading

Imagem

Figure 2. Triadin peptides modulate purified RyR1. (A) Running histogram of a typical bilayer experiment
Figure 3. Triadin peptide modulates purified RyR1 single channel open time, closed time and closed frequency
Figure 4. Triadin peptide does not activate mutant or native RyR1, or when its RyR1 binding site is blocked

Referências

Documentos relacionados

Comparison between the effects of two nicotinic receptor antagonists ( d -tubocurarine and ␣ -bungarotoxin) and ␮ -conotoxin GIIIB, a sodium channel blocker in skeletal muscle,

For a given sub- maximal stimulation, the combined effects of potentiation and fatigue could result in an increase, no change or a decrease in active force, depending on the

The parameters used to assess MM were calf circumference (CC) and skeletal muscle mass (SMM) through bioelectrical impedance (BIA) and the skeletal muscle index (SMI)

Effects of pre-irradiation of low-level laser therapy with different doses and wavelengths in skeletal muscle performance, fatigue, and skeletal muscle damage induced by

The terms fatty acids; oleic and linoleic acid; muscle function and trophism; plasticity and muscle trophism; skeletal muscle regeneration; skeletal muscle repair; muscle

he ith quintile of percent of skeletal muscle mass (SMM%), skeletal muscle to body fat ratio (MFR), and skeletal muscle to visceral fat ratio (SVR) accounted for the

Objective: To investigate the role of Acylation Stimulating Protein (ASP) receptor C5L2 in skeletal muscle fatty acid accumulation and metabolism as well as insulin sensitivity in

As shown for pRyR1Ser 2843 , fiber type- specific pAMPKThr 172 levels were determined in consecutive cross-sections of myofibers stained for pAMPKThr 172 and MyHC I at baseline